Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study.

Lancet

29 September Sep 2010 15 years ago
  • Swedberg K, Komajda M, Böhm M, Borer JS, Ford I, Dubost-Brama A, Lerebours G, Tavazzi L; SHIFT Investigators (tra i collaboratori Agostoni P)